x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
Long-term, prospective, observational, multinational,parallel-cohort study monitoring safety in patients with MS newly started with fingolimod once daily or treated with another approved disease-modifying therapy
Principal Investigator (?)
Study Number
F12059
Summary
The purpose of this world-wide prospective parallel-cohort study in patients with relapsing forms of MS, either newly treated with fingolimod or receiving another disease-modifying therapy, is to further explore the incidence of selected safety- related outcomes and to further monitor the overall safety profile of fingolimod under conditions of routine medical practice. 
Phase (?)
Phase III
Sponsor (?)
Contact

Charlotte Jeffreys

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0